NASDAQ:SLQD iShares 0-5 Year Investment Grade Corporate Bond ETF (SLQD) Price, Holdings, & News → Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad) Free SLQD Stock Alerts $48.89 +0.05 (+0.10%) (As of 12:14 PM ET) Add Compare Share Share Today's Range$48.87▼$48.9150-Day Range$48.75▼$49.2752-Week Range$47.65▼$49.41Volume22,127 shsAverage Volume259,142 shsMarket Capitalization$2.10 billionAssets Under Management$2.10 billionDividend Yield3.21%Net Expense Ratio0.06% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipShort InterestSocial Media Get iShares 0-5 Year Investment Grade Corporate Bond ETF alerts: Email Address About iShares 0-5 Year Investment Grade Corporate Bond ETF (NASDAQ:SLQD)The iShares 0-5 Year Investment Grade Corporate Bond ETF (SLQD) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a market-value-weighted index of investment-grade, USD-denominated corporate bonds with 0-5 years remaining to maturity. SLQD was launched on Oct 15, 2013 and is managed by BlackRock.Read More SLQD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SLQD ETF News HeadlinesApril 17, 2024 | finance.yahoo.comiShares 0-5 Year Investment Grade Corporate Bond ETF (SLQD.MX)December 2, 2023 | msn.comiShares 0-5 Year Investment Grade Corporate Bond ETF declares monthly distribution of $0.1366April 26, 2024 | Behind the Markets (Ad)Jim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.November 5, 2023 | investing.comSLQD ETF Stock Price HistoryNovember 3, 2023 | msn.comiShares 0-5 Year Investment Grade Corporate Bond ETF declares monthly distribution of $0.1346October 16, 2023 | seekingalpha.comSLQD: No Good Reason To Own This ETFAugust 14, 2023 | seekingalpha.comSLQD: Higher For LongerAugust 4, 2023 | seekingalpha.comiShares 0-5 Year Investment Grade Corporate Bond ETF declares monthly distribution of $0.1228April 26, 2024 | Behind the Markets (Ad)Jim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.August 2, 2023 | uk.investing.comiShares Corporate Bond 0-5 UCITS (IS15)See More Headlines Receive SLQD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares 0-5 Year Investment Grade Corporate Bond ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares 0-5 Year Investment Grade Corporate Bond ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:SLQD Inception Date10/15/2013 Fund ManagerJames Mauro, Karen Uyehara WebN/A Phone14089961010Fund Focus Asset ClassFixed Income BenchmarkMarkit iBoxx USD Liquid Investment Grade 0-5 Index CategoryCorporate FocusInvestment Grade Development LevelDeveloped Markets RegionNorth America Number of Holdings2537 Fund Statistics Assets Under Management$2.10 billion Average Daily Volume$165,944.30 Discount/Premium0.01% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest70,000 shs Miscellaneous Outstanding Shares42,900,000Beta0.10 Creation Unit50,000 Creation Fee$100.00 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... iShares 0-5 Year Investment Grade Corporate Bond ETF ExpensesTypeSLQDInvestment Grade ETFsFixed Income ETFsNASDAQ ETFsAll ETFsManagement Fee0.06%0.22%0.32%0.48%0.51%Other Expenses0.00%0.12%0.27%0.34%0.58%Total Expense0.06%0.25%0.40%0.58%0.70%Fee Waiver0.00%-0.15%-0.24%-0.22%-0.57%Net Expense0.06%0.22%0.35%0.54%0.58% iShares 0-5 Year Investment Grade Corporate Bond ETF (SLQD) Holdings & ExposureTop 10 SLQD HoldingsBlackRock Cash Funds Treasury SL AgencyHolding Weight: 0.74%CVS Health Corp 4.3%Holding Weight: 0.22%Comcast Corporation 4.15%Holding Weight: 0.20%The Boeing Company 2.2%Holding Weight: 0.20%Verizon Communications Inc. 4.33%Holding Weight: 0.20%Bank of America Corp. 3.42%Holding Weight: 0.19%Bank of America Corp. 1.73%Holding Weight: 0.18%Amgen Inc. 5.15%Holding Weight: 0.17%Charter Communications Operating, LLC/Charter Communications Operating CapiHolding Weight: 0.17%Goldman Sachs Group, Inc. 1.95%Holding Weight: 0.17%SLQD Sector ExposureSLQD Industry ExposureFull Holdings Details Similar ETFsInvesco BulletShares 2027 Corporate Bond ETFNASDAQ:BSCRInvesco BulletShares 2028 Corporate Bond ETFNASDAQ:BSCSInvesco BulletShares 2026 Corporate Bond ETFNASDAQ:BSCQiShares ESG Aware USD Corporate Bond ETFNASDAQ:SUSCVanguard Total Corporate Bond FundNASDAQ:VTCInstitutional OwnershipSummit Financial LLCSold 16,091 shares on 4/25/2024Ownership: 0.215%Christopher J. Hasenberg IncBought 632 shares on 4/25/2024Ownership: 0.001%Farmers & Merchants Investments Inc.Bought 1,747 shares on 4/18/2024Ownership: 2.357%NBC Securities Inc.Sold 2,717 shares on 4/5/2024Ownership: 0.018%Strategic Advocates LLCBought 780 shares on 4/3/2024Ownership: 0.040%View All Institutional Transactions SLQD ETF - Frequently Asked Questions How have SLQD shares performed in 2024? iShares 0-5 Year Investment Grade Corporate Bond ETF's stock was trading at $49.20 at the beginning of the year. Since then, SLQD stock has decreased by 0.6% and is now trading at $48.89. View the best growth stocks for 2024 here. Are investors shorting iShares 0-5 Year Investment Grade Corporate Bond ETF? iShares 0-5 Year Investment Grade Corporate Bond ETF saw a increase in short interest in April. As of April 15th, there was short interest totaling 84,900 shares, an increase of 21.3% from the March 31st total of 70,000 shares. Based on an average trading volume of 237,400 shares, the days-to-cover ratio is presently 0.4 days. View iShares 0-5 Year Investment Grade Corporate Bond ETF's Short Interest. How often does iShares 0-5 Year Investment Grade Corporate Bond ETF pay dividends? What is the dividend yield for iShares 0-5 Year Investment Grade Corporate Bond ETF? iShares 0-5 Year Investment Grade Corporate Bond ETF announced a monthly dividend on Thursday, March 28th. Investors of record on Tuesday, April 2nd will be paid a dividend of $0.1473 per share on Friday, April 5th. This represents a $1.77 dividend on an annualized basis and a dividend yield of 3.62%. The ex-dividend date of this dividend is Monday, April 1st. Read our dividend analysis for SLQD. What does SLQD invest in? iShares 0-5 Year Investment Grade Corporate Bond ETF is a fixed income fund issued by iShares. SLQD focuses on investment grade investments and follows the Markit iBoxx USD Liquid Investment Grade 0-5 Index. The fund's investments total to approximately $2.10 billion assets under management. What is the management fee for iShares 0-5 Year Investment Grade Corporate Bond ETF? iShares 0-5 Year Investment Grade Corporate Bond ETF's management fee is 0.06% and has no other recorded expenses or fee waivers. The net expense ratio for SLQD is 0.06%. What other stocks do shareholders of iShares 0-5 Year Investment Grade Corporate Bond ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares 0-5 Year Investment Grade Corporate Bond ETF investors own include AT&T (T), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Corcept Therapeutics (CORT), Fate Therapeutics (FATE), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Johnson & Johnson (JNJ), Kornit Digital (KRNT) and OPKO Health (OPK). Who are iShares 0-5 Year Investment Grade Corporate Bond ETF's major shareholders? iShares 0-5 Year Investment Grade Corporate Bond ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include Farmers & Merchants Investments Inc. (2.36%), Summit Financial LLC (0.21%), Strategic Advocates LLC (0.04%), NBC Securities Inc. (0.02%) and Christopher J. Hasenberg Inc (0.00%). How do I buy shares of iShares 0-5 Year Investment Grade Corporate Bond ETF? Shares of SLQD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SLQD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares 0-5 Year Investment Grade Corporate Bond ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.